AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Endoglim Trio 3mg/500mg/0.3mg Tablet

Prescription Icon
Prescription Required

Marketer

Arkas Pharma Pvt Ltd

Salt Composition

Glimepiride (3mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Endoglim Trio 3mg/500mg/0.3mg Tablet

Triomine Diabetic Therapy (3mg/500mg/0.3mg) is an antidiabetic medication combining three agents to manage type 2 diabetes in adults. This formulation helps regulate blood glucose. Administer Triomine with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic potential. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring and potential blood tests (blood cell counts, liver function) are recommended under physician supervision.

Uses of Endoglim Trio 3mg/500mg/0.3mg Tablet

Managing type 2 diabetes

Major Benefits of Endoglim Trio 3mg/500mg/0.3mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Endoglim Trio 3mg/500mg/0.3mg tablets on an empty stomach.

Common Side effects of Endoglim Trio 3mg/500mg/0.3mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Endoglim Trio 3mg/500mg/0.3mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Endoglim Trio 3mg/500mg/0.3mg Tablet whole; do not break, crush, or chew it. Administer on an empty stomach.

How Endoglim Trio 3mg/500mg/0.3mg Tablet works:

Endoglim Trio tablets (3mg/500mg/0.3mg) combine three antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Endoglim Trio 3mg/500mg/0.3mg tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Endoglim Trio 3mg/500mg/0.3mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Endoglim Trio 3mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Preliminary evidence from human studies indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience such symptoms.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Endoglim Trio 3mg/500mg/0.3mg Tablets due to potential safety concerns. Medical advice is necessary before use. The use of Endoglim Trio 3mg/500mg/0.3mg Tablets is discouraged in individuals with severe kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should use Endoglim Trio 3mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For individuals with mild to moderate hepatic dysfunction, initiation with a reduced Endoglim Trio 3mg/500mg/0.3mg tablet dosage is typical; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Endoglim Trio 3mg/500mg/0.3mg Tablet :

Should you forget a dose of Endoglim Trio 3mg/500mg/0.3mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Endoglim Trio 3mg/500mg/0.3mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Endoglim Trio 3mg/500mg/0.3mg Tablet

Endoglim Trio tablets (3mg/500mg/0.3mg) contain glimepiride, metformin, and voglibose. This triple-drug formulation manages type 2 diabetes mellitus in adults, enhancing glycemic control when combined with a suitable diet and exercise regimen. Glimepiride stimulates pancreatic insulin secretion, reducing blood glucose. Metformin decreases hepatic glucose production and increases insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal blood sugar spikes. This medication is unsuitable for type 1 diabetes.
Taking Endoglim Trio 3mg/500mg/0.3mg Tablets may result in side effects such as low blood sugar, queasiness, loose stools, changes in taste perception, gas, abdominal discomfort, head pain, skin eruptions, and upper respiratory illness.
Patients with hypersensitivity to Endoglim Trio 3mg/500mg/0.3mg Tablet constituents or inactive ingredients should not use this medication. Its administration is contraindicated in individuals with moderate to severe nephropathy, and those suffering from inflammatory bowel disorders, colonic ulcers, or underlying metabolic acidosis, encompassing diabetic ketoacidosis.
Consuming alcohol concurrently with Endoglim Trio 3mg/500mg/0.3mg tablets is unsafe. This combination can lead to dangerously low blood sugar (hypoglycemia) and heighten the risk of lactic acidosis.
Indeed, Endoglim Trio 3mg/500mg/0.3mg Tablets may induce hypoglycemia. Low blood sugar can manifest as nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Always carry readily available glucose sources, such as glucose tablets, honey, or fruit juice.
Retain this medication within its original, sealed packaging. Follow the storage directions provided on the package or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Endoglim Trio 3mg/500mg/0...
144
MRP 176
18% off